(a)
|
|
•
|
CLO AAAs have the highest priority payments and are backed by diverse portfolios of primarily first lien, senior secured corporate debt
|
|
•
|
CLO AAAs have never defaulted in the history of the asset class
|
|
•
|
CLOs are floating rate instruments that pay a spread over a benchmark rate such as Secured Overnight Financing Rate (“SOFR”). As of February 29, 2024, the Fund had a yield of 6.52%1
|
|
•
|
CLOs have low correlation to public debt and equity markets
|
1.
|
Based on the 30-Day SEC Yield
|
|
2.
|
Source: S&P Global – “CLO Spotlight: U.S. CLO Tranche Defaults As Of July 27, 2023” (8/9/2023)
|
|
3.
|
Source: S&P Global – “Default, Transition, and Recovery: 2022 Annual Global Corporate Default and Rating Transition Study” (4/25/2023)
|
|
4.
|
Source: Bloomberg (2/29/2024)
|
|
5.
|
Source: Citi Research – “Cross Asset Correlation” (12/31/2022). Based on data between January 2013 and December 2022.
|
|
Past performance is not indicative of, or a guarantee of, future results. The information shown here is for background purposes only.
|
•
|
As of February 29, 2024, the Fund’s Net Asset Value reached $54.7 million.
|
|
•
|
The Fund was invested in approximately 97.8% CLO AAA bonds and 2.2% cash and cash equivalents.
|
|
•
|
For the six months ended February 29, 2024, the Fund returned 3.96% on a net asset value basis and 4.09% on a market price basis.
|
|
•
|
The Fund’s benchmark, the JP Morgan CLO AAA Index, returned 4.10% during this period.
|
|
•
|
From inception through February 29, 2024, the Fund returned 5.40% on a net asset value basis and 5.55% on a market price basis, compared to the benchmark return of 5.45% for the same period.
|
![]() |
![]() |
John E. Kim
|
Timothy P. Wickstrom Jr.
|
Portfolio Manager
|
Portfolio Manager
|
Since Inception(1)
|
|
Panagram AAA CLO ETF – NAV
|
5.40%
|
Panagram AAA CLO ETF – Market
|
5.55%
|
J.P. Morgan CLOIE AAA Index(2)
|
5.45%
|
(1)
|
Inception date of the Fund was July 18, 2023.
|
(2)
|
The J.P. Morgan CLOIE AAA Index is designed to track the performance of broadly-syndicated, arbitrage US CLO debt. The J.P. Morgan CLOIE AAA Index is a sub-index of the J.P. Morgan CLOIE Index that incorporates
both AAAs and Junior AAAs.
|
Expenses Paid
|
||||
Annualized Net
|
Beginning
|
Ending
|
During Period(1)
|
|
Expense Ratio
|
Account Value
|
Account Value
|
(9/01/2023 to
|
|
(2/29/2024)
|
(9/01/2023)
|
(2/29/2024)
|
2/29/2024)
|
|
Actual(2)
|
0.20%
|
$1,000.00
|
$1,039.60
|
$1.01
|
Hypothetical (5% annual return before expenses)
|
0.20%
|
$1,000.00
|
$1,023.87
|
$1.01
|
(1)
|
Expenses are equal to the Fund’s annualized expense ratio for the period multiplied by the average account value over the period, multiplied by 182/366 to reflect its six-month period.
|
(2)
|
Based on the actual NAV returns for the period from September 1, 2023 through February 29, 2024, of 3.96%.
|
Palmer Square CLO 2023-1 Ltd.
|
|||||
Series 2023-1A Class A, 7.22%, 1/20/2036
|
3.68
|
%
|
|||
Madison Park Funding LXII Ltd.
|
|||||
Series 2022-62A Class AR, 7.17%, 7/17/2036
|
3.67
|
%
|
|||
Ares Loan Funding IV Ltd.
|
|||||
Series 2023-ALF4A Class A1, 7.10%, 10/15/2036
|
3.67
|
%
|
|||
Ares LVI CLO Ltd. Series 2020-56A Class AR, 6.75%, 10/25/2034
|
3.67
|
%
|
|||
Neuberger Berman Loan Advisers CLO 47 Ltd.
|
|||||
Series 2022-47A Class A, 6.62%, 4/14/2035
|
3.66
|
%
|
|||
Benefit Street Partners CLO X Ltd.
|
|||||
Series 2016-10A Class A1RR, 6.79%, 4/20/2034
|
3.66
|
%
|
|||
Elmwood CLO XII Ltd. Series 2021-5A Class A, 6.73%, 1/20/2035
|
3.66
|
%
|
|||
Harriman Park CLO Ltd. Series 2020-1A Class A1R, 6.70%, 4/20/2034
|
3.66
|
%
|
|||
Madison Park Funding XXXIV Ltd.
|
|||||
Series 2019-34A Class AR, 6.71%, 4/25/2032
|
3.65
|
%
|
|||
Carlyle US CLO 2020-2 Ltd. Series 2020-2A Class A1R, 6.73%, 1/25/2035
|
3.65
|
%
|
(1)
|
Fund Holdings are subject to change at any time and are not recommendations to buy or sell any security.
|
Principal
|
||||||||
Amount
|
Value
|
|||||||
COLLATERALIZED LOAN OBLIGATIONS – 96.99% (a)(b)
|
||||||||
Cayman Islands – 86.68%
|
||||||||
AGL Core CLO 4 Ltd.
|
||||||||
Series 2020-4A, Class A1R, 6.65% (CME Term SOFR 3 Month + 1.33%),
|
||||||||
04/20/2033 (c)
|
$
|
1,500,000
|
$
|
1,499,646
|
||||
Apidos CLO XXXII
|
||||||||
Series 2019-32A, Class A1, 6.90% (CME Term SOFR 3 Month + 1.58%),
|
||||||||
01/20/2033 (c)
|
1,000,000
|
1,001,649
|
||||||
Apidos CLO XXXVII
|
||||||||
Series 2021-37A, Class A, 6.71% (CME Term SOFR 3 Month + 1.39%),
|
||||||||
10/22/2034 (c)
|
1,500,000
|
1,501,134
|
||||||
Ares LVI CLO Ltd.
|
||||||||
Series 2020-56A, Class AR, 6.75% (CME Term SOFR 3 Month + 1.42%),
|
||||||||
10/25/2034 (c)
|
2,000,000
|
2,003,596
|
||||||
Ares LXI CLO Ltd.
|
||||||||
Series 2021-61A, Class A, 6.73% (CME Term SOFR 3 Month + 1.41%),
|
||||||||
10/20/2034 (c)
|
1,500,000
|
1,501,290
|
||||||
Ballyrock CLO 18 Ltd.
|
||||||||
Series 2021-18A, Class A1, 6.73% (CME Term SOFR 3 Month + 1.41%),
|
||||||||
01/15/2035 (c)
|
1,115,000
|
1,115,617
|
||||||
Benefit Street Partners CLO X Ltd.
|
||||||||
Series 2016-10A, Class A1RR, 6.79% (CME Term SOFR 3 Month + 1.47%),
|
||||||||
04/20/2034 (c)
|
2,000,000
|
2,001,802
|
||||||
Benefit Street Partners CLO XXI Ltd.
|
||||||||
Series 2020-21A, Class A1R, 6.75% (CME Term SOFR 3 Month + 1.43%),
|
||||||||
10/15/2034 (c)
|
1,000,000
|
1,001,281
|
||||||
Carlyle US CLO 2020-2 Ltd.
|
||||||||
Series 2020-2A, Class A1R, 6.73% (CME Term SOFR 3 Month + 1.40%),
|
||||||||
01/25/2035 (c)
|
2,000,000
|
1,996,492
|
||||||
Carlyle US CLO 2021-2 Ltd.
|
||||||||
Series 2021-2A, Class A1, 6.66% (CME Term SOFR 3 Month + 1.34%),
|
||||||||
04/20/2034 (c)
|
1,515,000
|
1,515,391
|
||||||
CIFC Funding 2020-II Ltd.
|
||||||||
Series 2020-2A, Class AR, 6.75% (CME Term SOFR 3 Month + 1.43%),
|
||||||||
10/20/2034 (c)
|
1,500,000
|
1,502,037
|
||||||
CIFC Funding 2020-IV Ltd.
|
||||||||
Series 2020-4A, Class A, 6.90% (CME Term SOFR 3 Month + 1.58%),
|
||||||||
01/15/2034 (c)
|
1,500,000
|
1,500,671
|
||||||
CIFC Funding 2022-II Ltd.
|
||||||||
Series 2022-2A, Class A1, 6.63% (CME Term SOFR 3 Month + 1.32%),
|
||||||||
04/19/2035 (c)
|
1,500,000
|
1,501,521
|
Principal
|
||||||||
Amount
|
Value
|
|||||||
Cayman Islands – 86.68% (Continued)
|
||||||||
Elmwood CLO V Ltd.
|
||||||||
Series 2020-2A, Class AR, 6.73% (CME Term SOFR 3 Month + 1.41%),
|
||||||||
10/20/2034 (c)
|
$
|
1,500,000
|
$
|
1,500,671
|
||||
Elmwood CLO XII Ltd.
|
||||||||
Series 2021-5A, Class A, 6.73% (CME Term SOFR 3 Month + 1.41%),
|
||||||||
01/20/2035 (c)
|
2,000,000
|
2,001,540
|
||||||
GoldenTree Loan Management US CLO 4 Ltd.
|
||||||||
Series 2019-4A, Class AR, 6.69% (CME Term SOFR 3 Month + 1.37%),
|
||||||||
04/24/2031 (c)
|
1,400,000
|
1,400,493
|
||||||
Harriman Park CLO Ltd.
|
||||||||
Series 2020-1A, Class A1R, 6.70% (CME Term SOFR 3 Month + 1.38%),
|
||||||||
04/20/2034 (c)
|
2,000,000
|
2,000,984
|
||||||
Madison Park Funding LXII Ltd.
|
||||||||
Series 2022-62A, Class AR, 7.17% (CME Term SOFR 3 Month + 1.85%),
|
||||||||
07/17/2036 (c)
|
2,000,000
|
2,010,711
|
||||||
Madison Park Funding XXXIV Ltd.
|
||||||||
Series 2019-34A, Class AR, 6.71% (CME Term SOFR 3 Month + 1.38%),
|
||||||||
04/25/2032 (c)
|
2,000,000
|
1,999,310
|
||||||
Magnetite XXVII Ltd.
|
||||||||
Series 2020-28A, Class AR, 6.71% (CME Term SOFR 3 Month + 1.39%),
|
||||||||
01/20/2035 (c)
|
1,000,000
|
1,002,080
|
||||||
Magnetite XXXVII Ltd.
|
||||||||
Series 2023-37A, Class A, 7.08% (CME Term SOFR 3 Month + 1.65%),
|
||||||||
10/20/2036 (c)
|
500,000
|
503,600
|
||||||
Neuberger Berman Loan Advisers CLO 43 Ltd.
|
||||||||
Series 2021-43A, Class A, 6.71% (CME Term SOFR 3 Month + 1.39%),
|
||||||||
07/17/2035 (c)
|
1,300,000
|
1,300,668
|
||||||
Neuberger Berman Loan Advisers CLO 47 Ltd.
|
||||||||
Series 2022-47A, Class A, 6.62% (CME Term SOFR 3 Month + 1.30%),
|
||||||||
04/14/2035 (c)
|
2,000,000
|
2,002,666
|
||||||
OHA Credit Funding 10 Ltd.
|
||||||||
Series 2021-10A, Class A, 6.69% (CME Term SOFR 3 Month + 1.39%),
|
||||||||
01/18/2036 (c)
|
1,500,000
|
1,500,689
|
||||||
OHA Credit Partners XVI Ltd.
|
||||||||
Series 2021-16A, Class A, 6.71% (CME Term SOFR 3 Month + 1.41%),
|
||||||||
10/18/2034 (c)
|
1,975,000
|
1,979,124
|
||||||
Palmer Square CLO 2019-1 Ltd.
|
||||||||
Series 2019-1A, Class A1R, 6.72% (CME Term SOFR 3 Month + 1.41%),
|
||||||||
11/14/2034 (c)
|
1,390,000
|
1,391,072
|
Principal
|
||||||||
Amount
|
Value
|
|||||||
Cayman Islands – 86.68% (Continued)
|
||||||||
Palmer Square CLO 2023-1 Ltd.
|
||||||||
Series 2023-1A, Class A, 7.22% (CME Term SOFR 3 Month + 1.90%),
|
||||||||
01/20/2036 (c)
|
$
|
2,000,000
|
$
|
2,012,799
|
||||
Reese Park CLO Ltd.
|
||||||||
Series 2020-1A, Class AR, 6.71% (CME Term SOFR 3 Month + 1.39%),
|
||||||||
10/15/2034 (c)
|
1,500,000
|
1,502,922
|
||||||
Regatta XVIII Funding Ltd.
|
||||||||
Series 2021-1A, Class A1, 6.68% (CME Term SOFR 3 Month + 1.36%),
|
||||||||
01/15/2034 (c)
|
1,500,000
|
1,500,390
|
||||||
Rockland Park CLO Ltd.
|
||||||||
Series 2021-1A, Class A, 6.70% (CME Term SOFR 3 Month + 1.38%),
|
||||||||
04/20/2034 (c)
|
1,200,000
|
1,200,889
|
||||||
TICP CLO XV Ltd.
|
||||||||
Series 2020-15A, Class A, 6.86% (CME Term SOFR 3 Month + 1.54%),
|
||||||||
04/20/2033 (c)
|
1,000,000
|
1,000,753
|
||||||
47,453,488
|
||||||||
Jersey — 10.31%
|
||||||||
Ares Loan Funding IV Ltd.
|
||||||||
Series 2023-ALF4A, Class A1, 7.10% (CME Term SOFR 3 Month + 1.75%),
|
||||||||
10/15/2036 (c)
|
2,000,000
|
2,008,145
|
||||||
Elmwood CLO 15 Ltd.
|
||||||||
Series 2022-2A, Class A1, 6.66% (CME Term SOFR 3 Month + 1.34%),
|
||||||||
04/22/2035 (c)
|
1,380,000
|
1,381,062
|
||||||
Symphony CLO 35 Ltd.
|
||||||||
Series 2022-35A, Class AR, 7.02% (CME Term SOFR 3 Month + 1.70%),
|
||||||||
10/24/2036 (c)
|
1,250,000
|
1,255,944
|
||||||
Valley Stream Park CLO Ltd.
|
||||||||
Series 2022-1A, Class AR, 6.95% (CME Term SOFR 3 Month + 1.63%),
|
||||||||
10/20/2034 (c)
|
1,000,000
|
1,000,896
|
||||||
5,646,047
|
||||||||
Total Collateralized Loan Obligations
|
||||||||
(Cost $52,692,247)
|
53,099,535
|
Shares
|
Value
|
|||||||
Money Market Funds – 2.19%
|
||||||||
First American Treasury Obligations Fund, Class X, 5.23% (d)
|
1,198,830
|
$
|
1,198,830
|
|||||
Total Money Market Funds
|
||||||||
(Cost $1,198,830)
|
1,198,830
|
|||||||
Total Investments – 99.18%
|
||||||||
(Cost $53,891,077)
|
54,298,365
|
|||||||
Other Assets in Excess of Liabilities – 0.82%
|
449,530
|
|||||||
Total Net Assets – 100.00%
|
$
|
54,747,895
|
(a)
|
Variable rate securities. The coupon is based on a reference index and spread. The rate reported is the rate in effect as of February 29, 2024.
|
(b)
|
To the extent the Fund invests more heavily in particular sectors or asset classes, its performance will be especially sensitive to developments that significantly affect those sectors or asset classes.
|
(c)
|
Securities exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional
investors. The value of these securities total $53,099,535, which represents 96.99% of total net assets.
|
(d)
|
The rate quoted is the annualized seven-day effective yield as of February 29, 2024.
|
ASSETS:
|
||||
Investments, at value (Cost $53,891,077)
|
$
|
54,298,365
|
||
Receivable for Fund shares sold
|
1,273,170
|
|||
Interest receivable
|
441,221
|
|||
Other receivable
|
1,910
|
|||
Total assets
|
56,014,666
|
|||
LIABILITIES:
|
||||
Payable for investments purchased
|
1,265,998
|
|||
Payable to Adviser
|
773
|
|||
Total liabilities
|
1,266,771
|
|||
NET ASSETS
|
$
|
54,747,895
|
||
NET ASSETS CONSIST OF:
|
||||
Paid-in capital
|
$
|
54,076,453
|
||
Total distributable earnings
|
671,442
|
|||
Total net assets
|
$
|
54,747,895
|
||
Net assets
|
$
|
54,747,895
|
||
Shares issued and outstanding(1)
|
2,150,000
|
|||
Net asset value
|
$
|
25.46
|
(1)
|
Unlimited shares authorized without par value.
|
INVESTMENT INCOME:
|
||||
Interest income
|
$
|
1,486,700
|
||
Total investment income
|
1,486,700
|
|||
EXPENSES:
|
||||
Investment advisory fees (See Note 3)
|
43,406
|
|||
Total expenses
|
43,406
|
|||
NET INVESTMENT INCOME
|
1,443,294
|
|||
REALIZED AND CHANGE IN UNREALIZED
|
||||
GAIN (LOSS) ON INVESTMENTS:
|
||||
Net realized gain (loss) on:
|
||||
Investments
|
—
|
|||
Net realized gain
|
—
|
|||
Net change in unrealized appreciation on:
|
||||
Investments
|
254,995
|
|||
Net change in unrealized appreciation
|
254,995
|
|||
Net realized and change in unrealized gain on investments
|
254,995
|
|||
NET INCREASE IN NET ASSETS
|
||||
RESULTING FROM OPERATIONS
|
$
|
1,698,289
|
For the
|
For the
|
|||||||
Six Months Ended
|
Period Inception
|
|||||||
February 29, 2024
|
through
|
|||||||
(Unaudited)
|
August 31, 2023(1)
|
|||||||
OPERATIONS:
|
||||||||
Net investment income
|
$
|
1,443,294
|
$
|
279,989
|
||||
Change in net unrealized appreciation on investments
|
254,995
|
152,293
|
||||||
Net increase in net assets resulting from operations
|
1,698,289
|
432,282
|
||||||
DISTRIBUTIONS TO SHAREHOLDERS:
|
||||||||
From distributable earnings (See Note 4)
|
(1,320,194
|
)
|
(138,935
|
)
|
||||
Total distributions to shareholders
|
(1,320,194
|
)
|
(138,935
|
)
|
||||
CAPITAL SHARE TRANSACTIONS:
|
||||||||
Proceeds from shares sold
|
18,995,460
|
35,000,000
|
||||||
Transaction fees
|
28,493
|
52,500
|
||||||
Net increase in net assets resulting from capital share transactions(2)
|
19,023,953
|
35,052,500
|
||||||
NET INCREASE IN NET ASSETS
|
19,402,048
|
35,345,847
|
||||||
NET ASSETS:
|
||||||||
Beginning of period
|
35,345,847
|
—
|
||||||
End of period
|
$
|
54,747,895
|
$
|
35,345,847
|
(1)
|
Inception date of the Fund was July 18, 2023.
|
(2)
|
A summary of capital share transactions is as follows:
|
For the Six Months Ended
|
For the Period Inception through
|
|||||||||||||||
February 29, 2024 (Unaudited)
|
August 31, 2023
|
|||||||||||||||
SHARE TRANSACTIONS:
|
Shares
|
Amount
|
Shares
|
Amount
|
||||||||||||
Issued
|
750,000
|
$
|
19,023,953
|
1,400,000
|
$
|
35,052,500
|
||||||||||
Net increase in shares outstanding
|
750,000
|
$
|
19,023,953
|
1,400,000
|
$
|
35,052,500
|
For the
|
For the
|
|||||||
Six Months Ended
|
Period Inception
|
|||||||
February 29, 2024
|
through
|
|||||||
(Unaudited)
|
August 31, 2023(1)
|
|||||||
PER SHARE DATA:
|
||||||||
Net asset value, beginning of period
|
$
|
25.25
|
$
|
25.00
|
||||
INVESTMENT OPERATIONS:
|
||||||||
Net investment income(2)
|
0.84
|
0.21
|
||||||
Net realized and unrealized gain on investments
|
0.13
|
0.10
|
||||||
Total from investment operations
|
0.97
|
0.31
|
||||||
LESS DISTRIBUTIONS:
|
||||||||
From net investment income
|
(0.77
|
)
|
(0.10
|
)
|
||||
Total distributions paid
|
(0.77
|
)
|
(0.10
|
)
|
||||
CAPITAL SHARE TRANSACTIONS:
|
||||||||
Transaction fees (see Note 5)
|
0.01
|
0.04
|
||||||
Total transaction fees
|
0.01
|
0.04
|
||||||
Net Asset Value, end of period
|
$
|
25.46
|
$
|
25.25
|
||||
Total return, at NAV(3)(4)
|
3.96
|
%
|
1.39
|
%
|
||||
Total return, at Market(3)(4)
|
4.09
|
%
|
1.40
|
%
|
||||
SUPPLEMENTAL DATA AND RATIOS:
|
||||||||
Net assets, end of period (in thousands)
|
$
|
54,748
|
$
|
35,346
|
||||
Ratio of expenses to average net assets(5)
|
0.20
|
%
|
0.20
|
%
|
||||
Ratio of net investment income to average net assets(5)
|
6.65
|
%
|
6.74
|
%
|
||||
Portfolio turnover rate(6)(7)
|
5
|
%(4)
|
0
|
%
|
(1)
|
Inception date of the Fund was July 18, 2023.
|
(2)
|
Calculated based on average shares outstanding during the period.
|
(3)
|
Total return in the table represents the rate that the investor would have earned or lost on an investment in the Fund, assuming reinvestment of distributions.
|
(4)
|
Not annualized for periods less than one year.
|
(5)
|
Annualized for periods less that one year.
|
(6)
|
Excludes in-kind transactions associated with creations of the Fund.
|
(7)
|
The numerator for the portfolio turnover rate includes the lesser of purchases or sales (excluding short-term investments and securities sold short). The denominator includes the average fair value of long
positions throughout the period.
|
A. Investment Valuation – The following is a summary of the Fund’s pricing procedures. It is intended to be a general discussion and may not necessarily reflect all the pricing procedures
followed by the Fund. Fixed income securities, including short-term debt instruments having a maturity of less than 60 days, are valued, at the evaluated mean price between the bid and asked prices in accordance with prices supplied by an
approved Pricing Service. Pricing Services may use various valuation methodologies such as matrix pricing and other analytical pricing models as well as market transactions and dealer quotations. In the absence of a price from a Pricing
Service, Fair Value will be determined by the Adviser pursuant to its valuation policies and procedures, and subject to Board oversight. These securities are categorized in Level 2 of the fair value hierarchy.
|
Level 1 –
|
Unadjusted quoted prices in active markets for identical assets or liabilities that the Fund has the ability to access.
|
Level 2 –
|
Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These inputs may include quoted prices for the identical instrument
on an inactive market, prices for similar instruments, interest rates, prepayment speeds, credit risk, yield curves, default rates and similar data.
|
Level 3 –
|
Unobservable inputs for the asset or liability, to the extent relevant observable inputs are not available, representing the Fund’s own assumptions about the assumptions a market participant would use in
valuing the asset or liability, and would be based on the best information available.
|
Investments at Fair Value
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||||||||||
Assets
|
||||||||||||||||
Collateralized Loan Obligations
|
$
|
—
|
$
|
53,099,535
|
$
|
—
|
$
|
53,099,535
|
||||||||
Money Market Funds
|
1,198,830
|
—
|
—
|
1,198,830
|
||||||||||||
Total
|
$
|
1,198,830
|
$
|
53,099,535
|
$
|
—
|
$
|
54,298,365
|
B. Cash and Cash Equivalents – The Fund considers highly liquid short-term fixed income investments purchased with an original maturity of less than three months and money market funds to be cash
equivalents. Cash equivalents are included in short term investments on the Schedule of Investments as well as in investments on the Statement of Assets and Liabilities. Temporary cash overdrafts are reported as payable to custodian.
|
C. Guarantees and Indemnifications – In the normal course of business, the Fund enters into contracts with service providers that contain general indemnification clauses. The Fund’s maximum
exposure under these arrangements is unknown, as this would involve future claims that may be made against the Fund that has not yet occurred.
|
D. Security Transactions, Income and Expenses – Investments in CLOs may be subject to certain tax provisions that could result in the Fund incurring tax or recognizing income prior to receiving
cash distributions related to such income. CLOs that fail to comply with certain U.S. tax disclosure requirements may be subject to withholding requirement that could adversely affect cash flows and investments results. Any unrealized
losses the Fund experiences with respect to its CLO investments may be an indication of future realized losses. Gain and losses on paydowns of CLOs are reflected in interest income on the Statements of Operations. The Fund follows industry
practice and records security transactions on the trade date. Realized gains and losses on sales of securities are calculated on the basis of identified cost. Dividend income is recorded on the ex-dividend date and interest income and
expense is recorded on an accrual basis. Withholding taxes on foreign dividends have been provided for in accordance with the Fund’s understanding of the applicable country’s tax rules and regulations. Discounts and premiums on securities
purchased are amortized over the expected life of the respective securities. Interest income is accounted for on the accrual basis and includes amortization of premiums and accretion of discounts on the effective interest method.
|
E. Share Valuation – The NAV per share of the Fund is calculated by dividing the sum of the value of the securities held by the Fund, plus cash or other assets, minus all liabilities (including
estimated accrued expenses) by the total number of shares outstanding for the Fund, rounded to the nearest cent. The Fund’s shares will not be priced on days which the New York Stock Exchange (“NYSE”) is closed for trading.
|
F. Use of Estimates – The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.
|
G. Statement of Cash Flows – Pursuant to the Cash Flows Topic of the Codification, the Fund qualifies for an exemption from the requirement to provide a statement of cash flows and has elected
not to provide a statement of cash flows.
|
Tax Cost of Investments
|
$
|
34,916,100
|
||
Gross unrealized appreciation
|
$
|
152,293
|
||
Gross unrealized depreciation
|
—
|
|||
Net unrealized appreciation
|
152,293
|
|||
Undistributed ordinary income
|
141,054
|
|||
Undistributed long-term capital gains
|
—
|
|||
Distributable earnings
|
141,054
|
|||
Other accumulated gains (loss)
|
—
|
|||
Total distributable earnings
|
$
|
293,347
|
Ordinary Income
|
Total Distributions Paid
|
||
2024
|
$1,320,194
|
$1,320,194
|
|
2023
|
$ 138,935
|
$ 138,935
|
Purchases
|
Sales
|
Creations In-Kind
|
Redemptions In-Kind
|
|||||||||||||
U.S. Government
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
||||||||
Other
|
$
|
20,306,876
|
$
|
2,000,000
|
$
|
—
|
$
|
—
|
•
|
Information we receive about you on applications or other forms;
|
|
•
|
Information you give us orally; and/or
|
|
•
|
Information about your transactions with us or others
|
(b)
|
Not applicable.
|
(a)
|
Schedule of Investments is included as part of the report to shareholders filed under Item 1 of this Form.
|
(b)
|
Not applicable.
|
(a)
|
The Registrant’s President and Treasurer have reviewed the Registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940 (the “Act”)) as of a date within 90 days of the filing of
this report, as required by Rule 30a-3(b) under the Act and Rules 13a-15(b) or 15d‑15(b) under the Securities Exchange Act of 1934. Based on their review, such officers have concluded that the disclosure controls and procedures are
effective in ensuring that information required to be disclosed in this report is appropriately recorded, processed, summarized and reported and made known to them by others within the Registrant and by the Registrant’s service provider.
|
(b)
|
There were no changes in the Registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the Act) that occurred during the period covered by this report that have materially affected, or are reasonably
likely to materially affect, the Registrant's internal control over financial reporting.
|
(a)
|
(1) Any code of ethics or amendment thereto, that is the subject of the disclosure required by Item 2, to the extent that the registrant intends to satisfy Item 2 requirements through filing an
exhibit. Not Applicable.
|